Shifts in Pharma-Marketing Trends in Post COVID-19 Era
DOI:
https://doi.org/10.11594/ijmaber.02.02.04Keywords:
Changing trends of marketing, pharma-marketing, digitalization of healthcare, post COVID-19Abstract
The study reveals that there will be shift in pharma-marketing trends in post COVID-19 era. The crisis of COVID-19, which responded in lockdowns and social distancing, highlighted in some key elements in the digital transformation of healthcare. Therewith the marketing techniques changes totally in the field of pharmaceuticals. As, this is an explorative research so qualitative data has been used for conducting the research. Secondary sources of data are used for analysis and interpretation and to develop the theoretical framework. Deductive approach is used in reaching the conclusive decision. Review of literature asserted about negative impacts of disruptions throughout the pandemics in past, yet these disruptions have also created some new opportunities. So to survive and to sustain pharmaceutical field and conjugate industries should now focus more on new marketing tactics, to counter COVID-19 side effects. Findings of the study educe that pharmaceutical industry could encounter the global pandemic by the shifts in pharma marketing strategies including advanced marketing, digital marketing, e-detailing customer relationship management, e-sampling, innovative work behavior, telemedicine revolution in order to promote product value and expediting prescriptions to the target consumer. So, coping up with the new normal and digitalizing the possible aspects of health care and medicines including techniques of pharma-marketing can be advantageous for both individuals and organizations.
Downloads
References
Downloads
Published
Issue
Section
License
Copyright (c) 2021 Md. Mahfuzur Rahman Khan, Kona Basak

This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See the Effect of Open Access).














